XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.99

+1.5%

Jan 29 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chris Boylan who wrote (8986)	3/8/1999 4:14:00 PM
From: xomadog2	Read Replies (1) of 17367

Dear Chris Boylan: I do not agree with your comments regarding the trial in phase 3 meningococcemia. It is not correct that the trial is being extended for a second time!!!! The only time that the trial was extended was at the sugeestion of the DSMB in September,after the last interim analysis. It is also not possible for you to have reason to believe that the company does not have statisically sufficient results to stop the trial. THE ISSUE FOR THE COMPANY to end the trial IS NOT STATISICALLY SUFFICIENT RESULTS.They are in need of having enough mortality(deaths) occur in the trial. This is not related to the efficacy hurdle that will be looked at after the number of minimum events is achieved in this trial. Please keep in mind that the assuming they have reached the minimum number of events and assuming that they decide based on the DSMB advice to end the trial..The data will stay unblinded until the follow up is done and the company is ready to unblind the data. There is also another phase 3 coming to completion in Trauma for the same drug. There is also,another possibility,source, of financing. GNE might be seriously enough interested in continuing the HU1124 trials that they fund the money upfront and enbale XOMA to have some money in the till.All the tools are around to buy time to get to the end of the meningococcemia trial,the trauma trial and ,see what the results for Neuprex are. If the results are positive, XOMA will have no problem arranging for new money. Yes, in a way this islike wildcat oil drilling.If you cant take the heat you always can sell or stay short. GOOD luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next